Top Markets
#1 COTI COTI +40.13%
#2 Binance-Peg Bitcoin Cash Binance-Peg Bitcoin Cash +32.72%
#3 Bitcoin Cash Bitcoin Cash +31.68%
#4 Fabric Protocol Fabric Protocol +31.09%
#5 GALA GALA +28.74%
#6 Tutorial Tutorial +27.35%
#7 Talus Network Talus Network +26.03%
#8 Magma Finance Magma Finance +24.61%
#9 Zora Zora +23.81%
#10 Arowana Arowana +22.89%
Coin of the day
COTI COTI
Ayarlar
Dil
TüRKçE
Para birimi
USD
Tema
Lytix Biopharma AS Lytix Biopharma AS

Lytix Biopharma AS

LYTIX
Hisse Senetlerindeki Sıralama #24450
Based in Oslo, Norway, Lytix Biopharma ASA is a clinical-stage biotechnology... Based in Oslo, Norway, Lytix Biopharma ASA is a clinical-stage biotechnology firm dedicated to advancing innovative immunotherapies for cancer treatment. Its primary drug candidate, LTX-315, is an oncolytic molecule currently undergoing Phase II clinical trials. This therapy is formulated for intratumoral injection, aiming to provide localized treatment for solid tumors. Additionally, Lytix Biopharma is developing LTX-401, another oncolytic molecule in its preclinical phase, specifically designed to target deep-seated cancerous lesions, including those found in liver cancer. The company was established in 2003.
Hisse Fiyatı
$0.78611575
Piyasa Değeri
$60.45M
Değişim (1 gün)
0.00%
Değişim (1 yıl)
-12.06%
Ülke
NO
Ticaret Lytix Biopharma AS (LYTIX)

Kategori

Healthcare
Lytix Biopharma AS (LYTIX) için kazanç
2026 itibarıyla kazanç TTM: 0
Lytix Biopharma AS şirketinin en son finansal raporlarına göre, mevcut kazancı 0'dir. 2026 yılında şirket 0 kazanç elde etti, bu 2026 yılındaki 0 kazanca göre önceki yıla eşit. Bu sayfada gösterilen kazanç, faiz ve vergiler öncesi kazançtır; yani EBIT.
Lytix Biopharma AS için kazanç geçmişi 2026 - 2026
Her yılın sonundaki kazanç
Yıl Kazanç Değiştir
Sağlanan tarihler için yeterli veri yok.
Benzer şirketler veya rakipler için kazanç
Şirket Kazanç Kazanç Farkı Ülke
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
$1.61B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH